The commission said it was concerned the company’s campaign to promote its Efluelda flu vaccine might amount to anticompetitive disparagement, portraying a rival shot as inferior to its own.
Source link
The commission said it was concerned the company’s campaign to promote its Efluelda flu vaccine might amount to anticompetitive disparagement, portraying a rival shot as inferior to its own.
Source link